The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans

Journal of Clinical Lipidology
Hanny WassefMay Faraj

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) shuttles low-density lipoprotein (LDL) receptors for degradation, thus upregulates LDL plasma clearance. Although PCSK9 loss of function is cardioprotective, its role in metabolic risks remains unknown. Increased apoB-lipoproteins uptake into nonhepatic tissues such as white adipose tissue (WAT) induces their dysfunction, which may be favored by lower plasma PCSK9. We hypothesized that lower plasma PCSK9 relative to apoB, or higher apoB-to-PCSK9 ratio, is a better predictor of metabolic disturbances than PCSK9 alone in humans. Thirty-three men and 48 postmenopausal women (>27 kg/m(2), aged 45-74 years, normoglycemic) underwent in-depth assessment of glucose and fat metabolism using high-fat meals, WAT biopsies, intravenous glucose-tolerance tests, and hyperinsulinemia clamps. Plasma apoB correlated positively with fasting and postprandial triglycerides and chylomicron clearance (R = 0.44-0.66) and glucose-stimulated insulin secretion (R = 0.24) and negatively with insulin sensitivity (R = -0.28) and gynoid WAT in situ lipoprotein lipase activity (ie, ex vivo WAT function, R(2) = 0.34). Neither PCSK9 nor LDL cholesterol associated with these risks. In regression analysis that...Continue Reading

References

Aug 2, 2002·Biochemical and Biophysical Research Communications·Akihiko KuniyasuHitoshi Nakayama
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nabil G SeidahMichel Chretien
May 6, 2003·Nature Genetics·Marianne AbifadelCatherine Boileau
Dec 23, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shui-Ping Zhao, Da-Qing Zhang
Jan 3, 2004·Journal of Lipid Research·May FarajKatherine Cianflone
Mar 31, 2004·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·May FarajKatherine Cianflone
Apr 13, 2005·Lancet·Michael StumvollTimon W van Haeften
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Jan 12, 2007·Trends in Biochemical Sciences·Jay D HortonHelen H Hobbs
Apr 15, 2008·Biochemical and Biophysical Research Communications·Robert J SchmidtGuoqing Cao
Apr 28, 2009·Current Opinion in Lipidology·Arnold von Eckardstein, Lucia Rohrer
Dec 1, 2012·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Michel Chrétien
Apr 12, 2014·Clinical Biochemistry·Zuhier AwanAlexis Baass
Jun 28, 2014·Diabetes Care·Giovanni CorraoGiuseppe Mancia
Mar 11, 2015·JAMA : the Journal of the American Medical Association·Joost BesselingG Kees Hovingh

❮ Previous
Next ❯

Citations

Feb 20, 2016·Journal of Endocrinological Investigation·S-H YangJ-J Li
Jan 15, 2016·Journal of Molecular Endocrinology·Michel Chrétien, Majambu Mbikay
Nov 9, 2016·Nutrition Research Reviews·Valérie LamantiaMay Faraj
Jan 11, 2019·Cardiovascular Research·Nabil G SeidahGiuseppe Danilo Norata

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.